NEW YORK and MAINZ, Germany, August 16, 2024 — Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced top-line results from their Phase 3 clinical trial
Screening for mid to large-caps, high (>2%) dividends, attractive or neutral rated, >5yr dividend history, positive cash flow stocks as of 8/12/24 data from YCharts revealed 52 potential buy to hold c
Novo Nordisk and Eli Lilly currently dominate the weight loss market thanks to their leading glucagon-like peptide-1 (GLP-1) receptor agonists. Their diabetes and obesity care medications are administ
Dividend Harvesting Portfolio saw a rebound after a volatile week in the market, with $13.12 profitability and $19.80 in dividend income generated. New additions to the portfolio include Alphabet, Bla

7 Dependable Dividend Stocks for Long-Term Income

06:44am, Wednesday, 14'th Aug 2024
From a long-term perspective, prolonged and stable returns often lead to dividend stocks. These types of stocks provide constant income and mark strong business fundamentals.
The outlook for pharmaceutical stocks has been mixed in the last five years. During the pandemic, the early-movers in the vaccine race gained as compared to others.
The current chaos that continues to roil the markets is creating a lot of headaches and material losses as major indices fall. It's also creating top investing opportunities to capitalize as prices di
Buying dividend stocks has proven to be a superior investing strategy. Because dividend payers tend to be large, successful businesses, they can better withstand the winds of market turmoil.
Results from a late-stage study show that Pfizer's (PFE) RSV vaccine generated strong neutralizing responses in immunocompromised adults after receiving a single dose.
Here we discuss three drugmakers, Eli Lilly and Company (LLY), Pfizer (PFE) and AbbVie (ABBV), following their increase in sales and earnings guidance for 2024.
We have narrowed our search to five large-cap stocks that have lagged the market year to date. These are: DDOG, SHOP, PFE, HES, PCG.

Pfizer: Growing Beyond Covid

10:00am, Tuesday, 13'th Aug 2024
Pfizer continues to transition to a strong future with reduced Covid drug sales. The biopharma has a strong lineup of new drugs whether via FDA approval or acquisition. The stock has a large dividend
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like BTU, PSMT, PFE, BBSI and GBX hold promise.
24/7 Wall St. Insights While it may come later this year or in 2025, recession odds are going higher on Wall Street.
The recent sell-off brought biopharma stocks down by a bit. Nothing has changed about their ability to compete.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE